424B4PROSPECTUS
Aug 7, 2026Final prospectus0001213900-26-086434
Sources: lifecycle-news, sec-harvest, sec-edgar, nasdaq
Now trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 1h ago
Public float and locked shares extracted from Ispecimen Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.
Needs review: Could not extract a detailed lock-up release schedule.
From SEC filings, latest FY ending Dec 31, 2023 · CIK 0001558569.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | $9.93M | $10.4M | $11.14M |
| Operating income | -$8.98M | -$12.73M | -$11.17M | -$10.19M | -$5.93M |
| Net income | -$10.49M | -$12.5M | -$11.1M | -$10.25M | -$8.96M |
| R&D expense | — | $1.49M | $1.62M | $1.47M | $879.24K |
| Cash & equivalents | $6.88M | $1.88M | $2.34M | $15.31M | $27.74M |
| Total assets | $9.53M | $9.35M | $15.82M | $24.62M | $35.72M |
| Total liabilities | $6.44M | $6.04M | $6.08M | $4.31M | $5.93M |
| Shareholders' equity | $3.09M | $3.31M | $9.74M | $20.31M | $29.79M |
EDGAR filings resolved from ISPC / CIK 0001558569.